Skip to Content

  • Search

View Additional Section Content

CALGB 80802 - Phase III Randomized Study of Sorafenib (IND 69896, NSC 724772) plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC).

Clinical Trial Categories

  • Liver/Hepatocellular
Contact
The Rosenfeld Cancer Center at 215-481-2402

Location

  • The Rosenfeld Cancer Center

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a Test
Request an Appointment

215-481-EXAM

Clinical Trials Details